| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Regional Bone Center, Helen Hayes Hospital West Haver straw, New York 10993
the Department of Pathology, Columbia University New York, New York 10032
Address all correspondence and requests for reprints to: Dr. D. W. Dempster, Regional Bone Center, Helen Hayes Hospital, Route 9W, West Haverstraw, New York 10993.
Abstract
Disaggregated chick osteoclasts sedimented onto bovine cortical bone slices excavate deep and sharply defined resorption lacunae that stain intensely with toluidine blue. We have used this observation to develop a simple light microscopic method for quantifying the bone resorptive activity of chick osteoclasts in vitro. Using this technique, we have found that disaggregated chick osteoclasts are strikingly less sensitive than rat osteoclasts to salmon calcitonin (sCT).
Bone resorption by rat osteoclasts was completely abolished by synthetic sCT at a concentration of 10 pg/ml. In contrast, sCT at concentrations up to 100 µg/ml did not significantly inhibit bone resorption by chick osteoclasts. Bone resorption by chick osteoclasts could, however, be inhibited by prostaglandin E2 at concentrations of 10-6 M or more. In time-lapse video experiments, the motility of rat osteoclasts was rapidly inhibited by sCT (5–50 pg/ml), prostaglandins I2 and E2 (
10-4 M), and Bu2cAMP (2.5 x 10-4 M), whereas chick osteoclasts failed to show such a response.
These findings suggest that CT does not play an important role in the regulation of osteoclastic activity in the chick and may explain why injection of the hormone has generally not been found to evoke an acute hypocalcemic response in. birds. This fundamental difference in response to CT may limit the utility of chick osteoclast systems as models of mammalian bone resorption (Endocrinology 120: 602–608,1987)
Footnotes
* This work was supported in part by the Citizens Advisory Council of Helen Hayes Hospital.
Present address: Department of Anatomy and Embryology, University College, London, Gower Street, London WClE 6BT, United Kingdom.
Received July 9, 1986.
This article has been cited by other articles:
![]() |
T. R. Arnett Extracellular pH Regulates Bone Cell Function J. Nutr., February 1, 2008; 138(2): 415S - 418S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Edwards, C. Cohen, W. Xu, and P. H. Schlesinger c-Src Control of Chloride Channel Support for Osteoclast HCl Transport and Bone Resorption J. Biol. Chem., September 22, 2006; 281(38): 28011 - 28022. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Destaing, F. Saltel, J.-C. Geminard, P. Jurdic, and F. Bard Podosomes Display Actin Turnover and Dynamic Self-Organization in Osteoclasts Expressing Actin-Green Fluorescent Protein Mol. Biol. Cell, February 1, 2003; 14(2): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Espinosa, L. Paret, C. Ojeda, Y. Tourneur, P. D. Delmas, and C. Chenu Osteoclast spreading kinetics are correlated with an oscillatory activation of a calcium-dependent potassium current J. Cell Sci., January 10, 2002; 115(19): 3837 - 3848. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meghji, M. S. Morrison, B. Henderson, and T. R. Arnett pH dependence of bone resorption: mouse calvarial osteoclasts are activated by acidosis Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E112 - E119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Hentunen, S. H. Jackson, H. Chung, S. V. Reddy, J. Lorenzo, S. J. Choi, and G. D. Roodman Characterization of Immortalized Osteoclast Precursors Developed from Mice Transgenic for Both bcl-XL and Simian Virus 40 Large T Antigen Endocrinology, July 1, 1999; 140(7): 2954 - 2961. [Abstract] [Full Text] |
||||
![]() |
M. S Morrison, L. Turin, B. F King, G. Burnstock, and T. R Arnett ATP is a potent stimulator of the activation and formation of rodent osteoclasts J. Physiol., September 1, 1998; 511(2): 495 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Lader and A. M. Flanagan Prostaglandin E2, Interleukin 1{alpha}, and Tumor Necrosis Factor-{alpha} Increase Human Osteoclast Formation and Bone Resorption in Vitro Endocrinology, July 1, 1998; 139(7): 3157 - 3164. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Solari, F Flamant, Y Cherel, M Wyers, and P Jurdic The osteoclast generation: an in vitro and in vivo study with a genetically labelled avian monocytic cell line J. Cell Sci., January 6, 1996; 109(6): 1203 - 1213. [Abstract] [PDF] |
||||
![]() |
P. Hill, G Murphy, A. Docherty, R. Hembry, T. Millican, J. Reynolds, and M. Meikle The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts J. Cell Sci., January 11, 1994; 107(11): 3055 - 3064. [Abstract] [PDF] |
||||
![]() |
G. D. Roodman Osteoclast Differentiation Critical Reviews in Oral Biology & Medicine, January 1, 1991; 2(3): 389 - 409. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |